Breakthrough research reveals how to target malignant DNA in aggressive cancers
Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the ...
Tag: Glioblastoma
Innovative CAR-T cells effectively target glioblastoma with reduced toxicity
Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than ...
Promising antidepressant offers hope for glioblastoma treatment
Glioblastoma is a particularly aggressive brain tumor that at present is incurable. Cancer doctors can extend patients' life expectancy through ...
Ultrasound technology breaks blood-brain barrier for glioblastoma treatment
In a major advance for the treatment of the deadly brain cancer glioblastoma, Northwestern Medicine scientists used ultrasound technology to ...
Unlocking glioblastoma's immune suppression mechanism
The Wistar Institute assistant professor Filippo Veglia, Ph.D., and team, have discovered a key mechanism of how glioblastoma -; a ...
Innovative CAR T cell therapy targets two proteins to combat aggressive brain tumor growth
In a recent report published in Nature Medicine, researchers presented the initial results of recurrent glioblastoma (rGBM) patients treated with ...
Researchers introduce CRISPR-mediated genome and cancer shredding as a conceptual paradigm to treat recurrent gliomas
In a recent study published in Cell Reports, researchers demonstrated clustered regularly interspersed short palindromic repeats (CRISPR)-mediated elimination of glioblastoma ...
Salk scientists find new immunotherapy treatment for glioblastoma
Glioblastoma, the most common and deadly form of brain cancer, grows rapidly to invade and destroy healthy brain tissue. The ...
Indirect inhibitors of cellular respiration for treatment of glioblastoma
A new research perspective was published in Oncotarget's Volume 14 on May 4, 2023, entitled, "Targeting cellular respiration as a ...
Cancer stem cell test can lead to increased survival for patients with glioblastoma
New multi-institutional phase 3 clinical trial data published May 2 in Cell Reports Medicine found that a cancer stem cell ...
